Actively Recruiting

Age: 18Years - 43Years
FEMALE
NCT04869007

The Impact of Cesarean Scar Defects on the Success of Assisted Human Reproduction

Led by University Hospital, Angers · Updated on 2025-07-23

250

Participants Needed

9

Research Sites

235 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The prevalence of Caesarean sections continues to increase around the world. In France, the proportion of Caesarean sections has doubled from 11% in 1981 to 20,2% in 2016, bringing with it an increase in the risk of obstetrical complications. Uterine defects, or Isthomcele, first defined by Morris in 1995 as a scarring abnormality with a dehiscence of the hysterotomy following a caesarean section. This purely iatrogenic pathology can cause inter-menstrual bleeding or pelvic pain. Several definitions of isthmosceles exist in scientific literature with variations according to the nature of the reference examination chosen and the measurements made. However, for the majority of authors, isthmoceles are characterized by a residual myometrial thickness of less than 3 millimetres in the sagittal plane. The prevalence of isthmoceles amoung patients with a unicicatricial uterus is about 61%. Currently, the main diagnostic technique for isthmoceles are 2D or 3D ultrasound and hysterosonography. Small, non-controlled studies have found that surgical treatment of the isthmocele is effective in reducing metrorrhagia. In these studies, the authors noted that patients with metrorrhagia were also more frequently affected by secondary infertility. A small number of non-comparative studies with a low level of evidence have looked into the efficacy of surgical treatment of isthmoceles on related symptoms: metrorraghia, pelvic pain and/or secondary infertility. Their results show an idiopathic secondary infertility rate in the presence of isthmoceles prior to surgical treatment of approximately 66%. Significantly higher pregnancy rates after treatment suggest that the surgical management of isthmoceles is worthwhile. However, these data suffer from not negligible selection bias. The initial findings concerning fertility after surgical repair seem promising and some teams propose systematic surgical management of the isthmocele before a technique of assisted reproduction (ART) although without any evidence in literature. Isthmocele surgery can result in uterine perforations, adhesions and intrauterine synechia known to be detrimental to future fertility. The efficacy of surgical management of surgey must therefore be demonstrated prior to any attempts at treatment. This will require large prospective studies based on a consensual definition of isthmocele. The diagnosis using Hysterosonography is currently considered as the "gold standard" examination. The main hypothesis of our study is that a significant isthmocele, defined by a residual myometrial thickness of less than 3mm, measured in the sagittal plane by hysterosonography, could alter the results of ART.

CONDITIONS

Official Title

The Impact of Cesarean Scar Defects on the Success of Assisted Human Reproduction

Who Can Participate

Age: 18Years - 43Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with a history of at least one cesarean section (single or multi-scarred uterus)
  • Age between 18 and 43 years old
  • Secondary infertility requiring ART techniques (FIV or FIV ICSI)
  • Undergoing hysterosonography as part of the pre-ART assessment to detect isthmocele presence
  • French speaking patients
  • Patients affiliated with or beneficiaries of a social security scheme
Not Eligible

You will not qualify if you...

  • Refusal to participate in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 9 locations

1

UH Angers

Angers, France, 49933

Actively Recruiting

2

University Hospital of Brest

Brest, France

Actively Recruiting

3

Hospital Center Sud Francilien

Corbeil-Essonnes, France

Actively Recruiting

4

Creteil University Hospital

Créteil, France

Actively Recruiting

5

University Hospital of Nimes

Nîmes, France

Actively Recruiting

6

Tenon Hospital Paris

Paris, France

Actively Recruiting

7

La Sagesse Clinic

Rennes, France

Actively Recruiting

8

University Hospital of Rennes

Rennes, France

Actively Recruiting

9

University Hospital of Saint Etienne

Saint-Etienne, France

Actively Recruiting

Loading map...

Research Team

G

Guillaume LEGENDRE, MD PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here